Ferenbach, David A.
Bonventre, Joseph V.
Article History
First Online: 3 February 2015
Competing interests
: J.V.B is co-inventor on KIM-1 patents that are assigned to Partners HealthCare and licensed to Johnson & Johnson, Sekisui, Novartis, Biogen Idec., R & D, and Astute. He is a consultant for Astellas, Novartis, Roche and Sekisui regarding the safety and efficacy of therapeutics or diagnostics for acute kidney injury. He holds equity in MediBeacon, Sentien and Thrasos, and has grant support from Novo Nordisk and Roche. D.A.F declares no competing interests.